Sarcoma
Volume 2008 (2008), Article ID 261589, 9 pages
doi:10.1155/2008/261589
Case Report

Outpatient and Home Chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor

Dolly Aguilera,1 Andrea Hayes-Jordan,2 Peter Anderson,1 Shiao Woo,3 Margaret Pearson,1 and Holly Green2

1Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
2Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Received 14 December 2007; Accepted 29 April 2008

Academic Editor: Chandrajit Raut

Copyright © 2008 Dolly Aguilera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. L. Gerald, M. Ladanyi, E. de Alava, et al., “Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants,” Journal of Clinical Oncology, vol. 16, no. 9, pp. 3028–3036, 1998.
  2. W. L. Gerald and J. Rosai, “Case 2. Desmoplastic small cell tumor with divergent differentiation,” Fetal and Pediatric Pathology, vol. 9, no. 2, pp. 177–183, 1989. View at Publisher · View at Google Scholar
  3. O. Glehen, F. Kwiatkowski, P. H. Sugarbaker, et al., “Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study,” Journal of Clinical Oncology, vol. 22, no. 16, pp. 3284–3292, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. P. H. Sugarbaker, “A curative approach to peritoneal carcinomatosis from colorectal cancer,” Seminars in Oncology, vol. 32, pp. S68–S73, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. P. H. Sugarbaker, O. A. Stuart, and D. Yoo, “Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy,” Journal of Oncology Pharmacy Practice, vol. 11, no. 3, pp. 111–119, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. P. H. Sugarbaker and K. A. Jablonski, “Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy,” Annals of Surgery, vol. 221, no. 2, pp. 124–132, 1995.
  7. A. Hayes-Jordan, P. Anderson, S. Curley, et al., “Continuous hyperthermic peritoneal perfusion: a surgical option for desmoplastic small round cell tumor (DSRCT),” Annals of Pediatric Surgery. In press.
  8. L. M. Wagner, K. R. Crews, L. C. Iacono, et al., “Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors,” Clinical Cancer Research, vol. 10, no. 3, pp. 840–848, 2004. View at Publisher · View at Google Scholar
  9. M. Casanova, A. Ferrari, G. Bisogno, et al., “Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol,” Journal of Pediatric Surgery, vol. 42, no. 8, pp. 29–32, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. D. R. Lal, W. T. Su, S. L. Wolden, K. C. Loh, S. Modak, and M. P. La Quaglia, “Results of multimodal treatment for desmoplastic small round cell tumors,” Journal of Pediatric Surgery, vol. 40, no. 1, pp. 251–255, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. M. Ladanyi and W. Gerald, “Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor,” Cancer Research, vol. 54, no. 11, pp. 2837–2840, 1994.
  12. B. H. Kushner, M. P. LaQuaglia, N. Wollner, et al., “Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy,” Journal of Clinical Oncology, vol. 14, no. 5, pp. 1526–1531, 1996.
  13. K. M. Skubitz, H. Hamdan, and R. C. Thompson, Jr., “Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas,” Cancer, vol. 72, no. 10, pp. 2963–2969, 1993. View at Publisher · View at Google Scholar
  14. G. Bisogno, R. Riccardi, A. Ruggiero, et al., “Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma,” Cancer, vol. 106, no. 3, pp. 703–707, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. P. M. Anderson and M. Pearson, “Novel therapeutic approaches in pediatric and young adult sarcomas,” Current Oncology Reports, vol. 8, no. 4, pp. 310–315, 2006. View at Publisher · View at Google Scholar
  16. P. M. Rosoff and S. Bayliff, “Successful clinical response to irinotecan in desmoplastic round blue cell tumor,” Medical and Pediatric Oncology, vol. 33, no. 5, pp. 500–503, 1999.
  17. R. Sakimura, K. Tanaka, F. Nakatani, et al., “Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors,” International Journal of Cancer, vol. 116, no. 5, pp. 784–792, 2005. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Liu, M. A. Knowling, P. Clarkson, J. M. Lubieniecka, H. Cheng, and T. O. Nielsen, “Clear cell sarcoma and other translocation-asssociated sarcomas are highly sensitive to histone deacetylase inhibitor MS-275,” in Proceedings of the 12th Annual Meeting of the Connective Tissue Oncology Society (CTOS '06), Venice, Italy, November 2006, abstract # 533:16.
  19. E. A. Keschman, G. Z. D'Amato, T. C. Windham, et al., “Effects of AKT and MTOR inhibition on human sarcoma cells,” in Proceedings of the 12th Annual Meeting of the Connective Tissue Oncology Society (CTOS '06), Venice, Italy, November 2006, Abstract # 578:69.
  20. S. M. Schuetze, W. A. Chow, J. Y. Blay, G. D. Demetri, and S. George, “AP23573 induced long-term tumor stability in 2 patiens with desmoplastic small round cell tumor (DSRCT),” in Proceedings of the 12th Connective Tissue Oncology Society Meeeting (CTOS '06), Venice, Italy, November 2006, Abstract # 561:52.
  21. K. Froberg, R. E. Brown, H. Gaylord, and C. Manivel, “Intra-abdominal desmoplastic small round cell tumor: immunohistochemical evidence for up-regulation of autocrine and paracrine growth factors,” Annals of Clinical & Laboratory Science, vol. 28, no. 6, pp. 386–393, 1998.
  22. S. Wilhelm, C. Carter, M. Lynch, et al., “Discovery and development of sorafenib: a multikinase inhibitor for treating cancer,” Nature Reviews Drug Discovery, vol. 5, no. 10, pp. 835–844, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. P. H. Sugarbaker, L. S. Welch, F. Mohamed, and O. Glehen, “A review of peritoneal mesothelioma at the Washington Cancer Institute,” Surgical Oncology Clinics of North America, vol. 12, no. 3, pp. 605–621, 2003. View at Publisher · View at Google Scholar
  24. C. G. Willett, S. V. Kozin, D. G. Duda, et al., “Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice,” Seminars in Oncology, vol. 33, no. 5, pp. S35–S40, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. R. Saab, J. D. Khoury, M. Krasin, A. M. Davidoff, and F. Navid, “Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience,” Pediatric Blood & Cancer, vol. 49, no. 3, pp. 274–279, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. O. Glehen, F. N. Gilly, and P. H. Sugarbaker, “New perspectives in the management of colorectal cancer: what about peritoneal carcinomatosis?,” Scandinavian Journal of Surgery, vol. 92, no. 2, pp. 178–179, 2003.
  27. D. B. Gough, J. H. Donohue, A. J. Schutt, et al., “Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach,” Annals of Surgery, vol. 219, no. 2, pp. 112–119, 1994. View at Publisher · View at Google Scholar
  28. O. Glehen, F. Mithieux, D. Osinsky, et al., “Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study,” Journal of Clinical Oncology, vol. 21, no. 5, pp. 799–806, 2003. View at Publisher · View at Google Scholar
  29. A. Gil, A. Gomez Portilla, E. A. Brun, and P. H. Sugarbaker, “Clinical perspective on desmoplastic small round-cell tumor,” Oncology, vol. 67, no. 3-4, pp. 231–242, 2004. View at Publisher · View at Google Scholar · View at PubMed
  30. A. G. de Oliveira-Filho, M. L. Miranda, F. L. Diz, R. M. Machado Guimarães, S. S. Aguiar, and J. M. Bustorff-Silva, “Use of radiofrequency for ablation of unresectable hepatic metastasis in desmoplastic small round cell tumor,” Medical and Pediatric Oncology, vol. 41, no. 5, pp. 476–477, 2003. View at Publisher · View at Google Scholar · View at PubMed
  31. G. Schueller, J. Kettenbach, R. Sedivy, et al., “Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo,” International Journal of Oncology, vol. 24, no. 3, pp. 609–613, 2004.
  32. M. Bond, M. L. Bernstein, A. Pappo, et al., “A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study,” Pediatric Blood & Cancer, vol. 50, no. 2, pp. 254–258, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. R. Benjamin, L. Gore, C. Dias, et al., “Activity of R1507, a fully humanized monoclonal antibody IGF-1R (insulin-like growth factor receptor)antagonist, in patients with Ewing's sarcoma noted in a phase I study,” in Proceedings of the 13th Annual Meeting of the Connective Tissue Oncology Society (CTOS '07), Seattle, Wash, USA, November 2007, abstract # 932:49.